Compositions useful for treating gastroesophageal reflux disease
AssigneeEDUSA Pharmaceuticals, Inc.
InventorsSuhail Nurbhai, Steven B. Landau
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treating GERD in a human subject in need of treatment. The method comprises orally administering to said subject an effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof, wherein the effective amount is from about one to about three daily doses of the compound and the dose is from about 0.2 mg to about 0.5 mg.
Claims22
A method of treating GERD in a human subject in need thereof comprising orally administering to said subject an effective amount of a compound represented by the following structure:
- or a pharmaceutically acceptable salt thereof, wherein the effective amount is from about one to about three daily doses of the compound and the dose is from about 0.2 mg to about 0.5 mg.
19-32. (canceled)
A method of treating n-GERD in a human subject in need thereof comprising orally administering to the subject an effect amount of DDP-733 and a proton pump inhibitor, wherein 0.5 mg of the DDP-733 and the proton pump inhibitor are present in a single composition.
35-36. (canceled)
Dependencies are inferred from the claim text.